CO [Chinard Bloodrp] CORRESP: May 10, 2013 Ms. Tia Jenkins Re: Chinard
[May 10, 2013 Ms. Tia Jenkins Re: Chinard Bloodrporation Dear Ms. Jenkins: Very truly yours, CHINARD BLOODRPORATION filename1.htm 1RRESP]
CO [China Cord Blood] CORRESP: (Original Filing)
[April 19, 2013 Tia L. Jenkins Re: China Cord Blood Corporation Form 20-F for Fiscal Year ended March 31, 2012 Filed July 31, 2012 File No. 001-34541 Dear Ms. Jenkins: Reference is made to the letter from the Commission’s staff (the “Staff”) dated March 19, 2013 regarding the Annual Report on Form 20-F for the fiscal year ended March 31,]
CO [China Cord Blood] CORRESP: April 19, 2013 Tia L. Jenkins Re: China
[April 19, 2013 Tia L. Jenkins Re: China Cord Blood Corporation Form 20-F for Fiscal Year ended March 31, 2012 Filed July 31, 2012 File No. 001-34541 Dear Ms. Jenkins: Reference is made to the letter from the Commission’s staff (the “Staff”) dated March 19, 2013 regarding the Annual Report on Form 20-F for the fiscal year ended March 31,]
CO [Chinard Bloodrp] CORRESP: (Original Filing)
[April 19, 2013 Tia L. Jenkins Re: Chinard Bloodrporation Form 20-F for Fiscal Year ended March 31, 2012 Filed July 31, 2012 File No. 001-34541 Dear Ms. Jenkins: Reference is made to the letter from themmissions staff (the Staff)ted March 19, 2013 regarding the Annual Report on Form 20-F for the fiscal year ended March]
CO [Chinard Bloodrp] CORRESP: April 19, 2013 Tia L. Jenkins Re: Chinard
[April 19, 2013 Tia L. Jenkins Re: Chinard Bloodrporation Form 20-F for Fiscal Year ended March 31, 2012 Filed July 31, 2012 File No. 001-34541 Dear Ms. Jenkins: Reference is made to the letter from themmissions staff (the Staff)ted March 19, 2013 regarding the Annual Report on Form 20-F for the fiscal year ended March]
CO [China Cord Blood] CORRESP: Loeb & Loeb LLP 345 Park Avenue Main
[Loeb & Loeb LLP 345 Park Avenue Main Fax April 16, 2013 Tia L. Jenkins Re: China Cord Blood Corporation Form 20-F for Fiscal Year ended March 31, 2012 Filed July 31, 2012 File No. 001-34541 Dear Ms. Jenkins: On behalf of our client, China Cord Blood Corporation, a Cayman Islands corporation (the “Company”), we hereby provide responses to comments]
